Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risks of blood transfusion.

Lawrence T Goodnough1

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110-1093, USA. goodnough@pathbox.wustl.edu

Critical Care Medicine
|January 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Authors' Reply to Michael Auerbach's Comment on: "Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System".

Drug safety·2021
Same author

Parenteral iron therapy and phosphorus homeostasis: A review.

American journal of hematology·2021
Same author

Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System.

Drug safety·2020
Same author

Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk.

Kidney medicine·2020
Same author

How I treat anemia in the perisurgical setting.

Blood·2020
Same author

Establishing a Satellite Transfusion Service Within an Academic Medical Center.

American journal of clinical pathology·2020

Blood transfusion safety has significantly improved, especially regarding viral infections. Key risks now include ABO incompatibility, lung injury, and bacterial contamination, necessitating advanced safety strategies.

Area of Science:

  • Transfusion Medicine
  • Hematology
  • Infectious Diseases

Background:

  • Blood transfusion remains a critical medical intervention.
  • Ensuring blood safety is paramount to patient care.
  • Historical risks have been significantly reduced over time.

Purpose of the Study:

  • To provide a comprehensive review of current blood transfusion risks.
  • To highlight advancements in blood safety measures.
  • To identify ongoing and emerging threats to transfusion safety.

Main Methods:

  • Systematic review of English-speaking literature.
  • Utilized key works and bibliographic citations for data synthesis.
  • Focused on human data relevant to transfusion risks.

Related Experiment Videos

Main Results:

  • Significant progress in reducing transfusion-transmitted viral infections over 20 years.
  • Current primary risks include administrative errors (ABO incompatibility), transfusion-related acute lung injury, and bacterial contamination of platelets.
  • Emerging pathogens like West Nile virus pose ongoing challenges.

Conclusions:

  • Blood safety has substantially advanced, particularly for viral infections.
  • Administrative errors, transfusion-related acute lung injury, and bacterial contamination are current major risks.
  • Proactive (pathogen inactivation) and reactive (nucleic acid testing) strategies are essential for future blood safety.